1 study found for:    21718522 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
Condition: Primary Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate;   Drug: Liposomal amphotericin B + miltefosine;   Drug: Miltefosine

Indicates status has not been verified in more than two years